A retrospective study of alemtuzumab level, t-cell chimerism and graft-versus-host disease using intermediate dose alemtuzumab for matched related and matched unrelated reduced-intensity transplantation

  1. Lookup NU author(s)
  2. Dr Wei Cope
  3. Dr Laura Jardine
  4. Dr Venetia Bigley
  5. Sarah Pagan
  6. Brie Turner
  7. Professor Graham Jackson
  8. Professor Anne Dickinson
  9. Professor Matthew Collin
Author(s)Morgan T, Cope W, Charlton A, Spence L, Bigley V, Groves N, Hale G, Pagan S, Turner B, Jones G, Jackson G, Dickinson A, Collin M
Publication type Conference Proceedings (inc. Abstract)
Conference Name36th Annual Meeting of the European Group for Blood and Marrow Transplantation/9th Meeting of the EBMT Data Management Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting
Conference LocationVienna, Austria
Year of Conference2010
Source Publication Date21-24 March 2010
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherBone Marrow Transplantation, Nature Publishing Group
Actions    Link to this publication
Library holdingsSearch Newcastle University Library for this item